Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • L-Alanyl-L-Glutamine: Technical Use Guide for GI Research

    2026-04-12

    L-Alanyl-L-Glutamine: Technical Guidance for GI Barrier and Nutritional Workflows

    What This Product Solves

    L-Alanyl-L-Glutamine (L-Ala-L-Gln dipeptide) is a synthetic dipeptide comprising L-alanine and L-glutamine, designed for stability and water solubility in laboratory settings. Standard L-glutamine is prone to rapid degradation and poor solubility in aqueous media, leading to inconsistencies in experimental reproducibility and loss of functional activity. By contrast, L-Alanyl-L-Glutamine offers a stable alternative that maintains integrity during preparation and storage, directly supporting workflows focused on intestinal barrier function enhancement, mucosal protection, and antioxidant system support [source_type: product_spec|workflow_recommendation]. This compound is highly applicable in enteral nutrition studies, gut barrier assays, and protocols examining inflammation attenuation within gastrointestinal models.

    Related internal resources offer mechanistic context and advanced protocol design: the article "L-Alanyl-L-glutamine: Mechanistic Mastery and Strategic L..." covers the molecular basis for intestinal mucosa protection, while "L-Alanyl-L-glutamine: Stable Dipeptide for Intestinal Bar..." details the compound's stability and workflow parameters.

    Protocol Parameters

    • assay | Solubility in water | ≥56.6 mg/mL | Enables preparation of concentrated stock solutions for cell culture or enteral administration without precipitation | product_spec | [source_link: https://www.apexbt.com/l-alanyl-l-glutamine.html]
    • assay | Storage temperature | -20°C | Maintains compound integrity and prevents degradation of the dipeptide during storage | product_spec | [source_link: https://www.apexbt.com/l-alanyl-l-glutamine.html]
    • assay | Solubility in DMSO/ethanol | Insoluble | Not suitable for protocols requiring organic solvent delivery; restrict use to aqueous systems | product_spec | [source_link: https://www.apexbt.com/l-alanyl-l-glutamine.html]
    • assay | Recommended solution storage duration | Prepare fresh; avoid long-term storage | Prevents breakdown and ensures reproducibility in sensitive assays involving antioxidant system support or intestinal barrier function enhancement | workflow_recommendation

    Workflow Setup and QC Checklist

    • Prepare solutions in sterile, deionized water only. Confirm full dissolution by gentle agitation and visual inspection; do not use DMSO or ethanol as solvents.
    • Aliquot powder upon receipt to minimize freeze-thaw cycles and store at -20°C. Incorporate desiccant in storage container to maintain dryness and prevent hydrolysis.
    • Use freshly prepared aqueous solutions for each experimental run; discard any unused solution after the protocol window to avoid degradation-related variability.
    • Verify compound identity and purity (98%) per lot using Certificate of Analysis when setting up new workflows.
    • Document batch numbers and preparation details in laboratory records to enable troubleshooting and reproducibility assessment.

    Common Failure Modes and Fixes

    • Precipitation in solution: Re-evaluate water quality and confirm not exceeding solubility limits (≥56.6 mg/mL). Avoid mixing with low-solubility additives or organic solvents.
    • Loss of activity upon storage: Prepare solutions immediately prior to use; do not store aqueous solutions long-term. Store powder at -20°C and minimize exposure to moisture.
    • Variable results in barrier or inflammation assays: Check for batch-to-batch consistency and verify purity. Ensure all protocol steps use water as solvent, and review lot-specific Certificate of Analysis.
    • Misapplication in non-aqueous protocols: L-Alanyl-L-Glutamine is unsuitable for DMSO- or ethanol-based delivery; use only in water-based models.

    Scope and Limitations

    This compound is designed for applications requiring reliable intestinal mucosa protection, enhancement of barrier function, and support for antioxidant systems in aqueous experimental models. It is not appropriate for studies needing organic solvent compatibility or protocols where long-term solution storage is required. Researchers should note that all quantitative specifications (solubility, purity, storage) are based on product data and not on published clinical or in vivo studies [source_type: product_spec]. No direct evidence is available for cross-domain applications outside gastrointestinal and nutritional supplementation contexts.

    Conclusion

    L-Alanyl-L-Glutamine (L-Ala-L-Gln dipeptide, SKU B8228) provides a robust, stable, and water-soluble option for protocols that demand consistent intestinal barrier function enhancement and antioxidant system support. Proper workflow setup—focusing on water-only dissolution, low-temperature powder storage, and immediate use of solutions—ensures reproducibility and minimizes variability. For detailed product specifications and documentation, refer to the official APExBIO page: L-Alanyl-L-Glutamine.